UBS Group’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $885K | Buy |
|
|||||
|
2025
Q2 | $17.1K | Sell |
|
|||||
|
2025
Q1 | $43.4K | Sell |
|
|||||
|
2024
Q4 | $115K | Buy |
|
|||||
|
2024
Q3 | $78.5K | Buy |
|
|||||
|
2024
Q2 | $9.03K | Sell |
|
|||||
|
2024
Q1 | $83.7K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $26.3K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $2K | Sell |
|
|||||
|
2022
Q2 | $8K | Sell |
|
|||||
|
2022
Q1 | $21K | Buy |
|
|||||
|
2021
Q4 | $26K | Buy |
|
|||||
|
2021
Q3 | $30K | Buy |
|